Global Cardiac Assist Devices Market- Market Dynamics
According to WHO, 17.5 million people deaths each year are from CVDs, around 31% of all deaths globally. According to US CDC, in 2012, 26.6 million adults were diagnosed with heart disease in the United States. American Heart Association predicted that 600,000 new cases of heart failure are detected each year in the US. This depicts the large global patient pool. There is growing incidence of cardiac diseases in developing countries.
Some of the factors driving the market for cardiac assist devices are:
Increasing patient population of various cardiovascular diseases
Shortage of donors for heart transplantation
Favorable reimbursement policies for cardiac assist devices
Technological advancement in Ventricular assist devices
Launch of new products
While there is ample scope for growth in the global cardiac assist devices market, there are several factors restraining it as well. These include:
Availability of alternative treatments like pacemakers
Risk associated with device implantation
The global cardiac assist devices market has been segmented into intra-aortic balloon pump, total artificial heart, ventricular assist device, and circulatory support device market. The Ventricular assist device market has been further subdivided into left ventricular assist device, right ventricular assist device, bi-ventricular assist device, and external ventricular assist device. The ventricular assist devices have the largest market share amongst cardiac assist devices.
The global cardiac assist device market has been segmented based on geography as North America, Europe, Asia-Pacific, Middle East and North Africa, and South America. The North America segment discusses different market trends, and market size of cardiac assist devices in the USA, Canada, and Mexico. The Europe segment has been further subdivided into the UK, France, Italy, Germany, Benelux, Scandinavia, Benelux, and Spain. The segmentation on Asia-Pacific has been subdivided into China, Japan, India, South Korea, Australia, and New Zealand. The Middle East & North Africa segment includes GCC, Egypt, and others. The South America region includes Brazil, Argentina, and others.
The United States has the largest market share in the global cardiac assist devices market. The increasing patient pool, favorable reimbursement policies in the United States and developed healthcare facilities are contributing to the large market share. Cardiac assist devices are being used as bridge to transplantation and bridge to recovery based on the requirement of the patient and the severity of the disease.
Due to technological advancement, it is expected that more efficient and minimally invasive devices are going to come up in the near future and drive the demand for cardiac assist devices. The maximum growth of cardiac assist devices is expected to be generated by the Ventricular Assist Devices (VAD) market. Thoratec Corporation is the leading provider of VADs, which controls half of the European market and 75% of the US market.
This Report Offers:
Market definition for the cardiac assist devices market, along with identification of key drivers and restraints for the market.
Market analysis for the cardiac assist devices market, with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the cardiac assist device market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
1.1 Study deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast period years
1.6 General Study Assumptions
2. Research Methodology
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry trends
5.1 Current Market Scenario
5.2 Cardiac Assisted devices Applications
5.3 Technology Overview
5.4 New Developments
5.5 Industry Value chain analysis
5.6 Product Lifecycle analysis
5.7 Product Benchmarking
5.8 Investment Analysis
5.9 Porter's Five Forces
5.9.1 Bargaining Power of Suppliers
5.9.2 Bargaining Power of Consumers
5.9.3 Threat to new entrants
5.9.4 Threat to substitute products and services
5.9.5 Competitive Rivalry within the industry
6. Drivers, Restraints, Opportunities Analysis
6.1 Market Drivers
6.1.1 New Product Launches
6.1.2 Aging Population
6.1.3 Increasing disease Prevalence
6.1.4 Shortage of Heart donor
6.1.5 Favorable Reimbursement Policies
6.2 Market Restraints
6.2.1 Stringent regulatory guidelines
6.2.2 Heart Transplantation
6.3 Market Opportunities
6.3.1 Technological advancements in VAD
7. Global Cardiac Assisted Devices Market segmentation
7.2 Segmentation by Product type
7.2.1 Intra-Aortic Balloon Pumps Market
7.2.2 Total Artificial Heart
7.2.3 Ventricular Assist Devices
18.104.22.168 Left Ventricular Assist Device
22.214.171.124 Right Ventricular Assist Device
126.96.36.199 Bi-Ventricular Assist Device
188.8.131.52 External Ventricular Assist Device
7.2.4 Circulatory Support Devices
8. Market segmentation by Geography - North America
8.1 North America
8.1.2 United States
8.2.3 United Kingdom
8.2.9 Rest of Europe
8.3 Asia-Pacific (APAC)
8.3.5 Australia and New Zealand
8.3.6 South Korea
8.3.7 Rest of Asia-Pacific
8.4 Middle East and North Africa
8.4.4 Rest of Middle East & Africa
8.5 South America
8.5.4 Rest of Latin America
9. Competitive Landscape
9.1 Merger and acquisition analysis
9.2 New Product Launches
9.3 Agreements, Collaborations, and Partnerships
10. Key Vendor Analysis
10.1 Abiomed Inc.
10.2 Berlin Heart GmbH
10.3 Bioheart, Inc.
10.4 BiVacor Pty Ltd.
10.5 Braile Biomedica Ltd.
10.6 Calon Cardio-Technology Ltd.
10.7 Cardiac Assist, Inc.
10.8 CardioBridge GmbH
10.9 CardioKinetix, Inc.
10.10 Circulite, Inc.
10.11 Cleveland Heart, Inc.
10.13 Thoratec Corporation
10.14 Teleflex Incorporated
10.15 SynCardia Systems
10.16 MyoCardioCare, Inc
10.17 Maquet Holding
11. Analyst outlook for Investment opportunities
12. Future Outlook of the market